Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
XXII 
22nd Century Group Inc (XXII)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: XXII (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $9
1 Year Target Price $9
| 0 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 0% | Avg. Invested days 0 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 01/09/2026 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 7.09M USD | Price to earnings Ratio - | 1Y Target Price 9 |
Price to earnings Ratio - | 1Y Target Price 9 | ||
Volume (30-day avg) 1 | Beta 1 | 52 Weeks Range 0.75 - 287.27 | Updated Date 01/8/2026 |
52 Weeks Range 0.75 - 287.27 | Updated Date 01/8/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 3182.71 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -33.43% | Operating Margin (TTM) -214.42% |
Management Effectiveness
Return on Assets (TTM) -27.17% | Return on Equity (TTM) -118.65% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 3038087 | Price to Sales(TTM) 0.35 |
Enterprise Value 3038087 | Price to Sales(TTM) 0.35 | ||
Enterprise Value to Revenue 0.39 | Enterprise Value to EBITDA -0.47 | Shares Outstanding 7652661 | Shares Floating 6228331 |
Shares Outstanding 7652661 | Shares Floating 6228331 | ||
Percent Insiders 4.2 | Percent Institutions 11.87 |
Upturn AI SWOT
22nd Century Group Inc
Company Overview
History and Background
22nd Century Group Inc. was founded in 1997. It is a plant biotechnology company that focuses on developing and growing proprietary hemp and cannabis plant lines. A significant milestone was its Nasdaq listing. The company has evolved from a focus on traditional tobacco products with reduced nicotine to a broader plant science company with applications in hemp and cannabis.
Core Business Areas
- Hemp & Cannabinoid Operations: Development and cultivation of proprietary hemp plant lines designed for high yields of specific cannabinoids (like CBD, CBG, etc.) for use in a variety of consumer products and research applications. This segment also includes potential future development of cannabis plants where legally permitted.
- Plant Science & Technology: Leveraging its expertise in plant genetics and breeding to develop novel plant varieties with specific traits. This could extend beyond hemp and cannabis to other agricultural applications.
Leadership and Structure
The leadership team is headed by a CEO and includes a CFO, COO, and other key executives responsible for operations, research and development, and sales. The organizational structure is designed to support its plant science focus and its agricultural operations.
Top Products and Market Share
Key Offerings
- Proprietary Hemp Plant Lines: 22nd Century Group develops and licenses proprietary hemp plant genetics. These lines are engineered for specific cannabinoid profiles and agricultural performance. Market share data is not readily available for specific plant genetics companies, but the hemp-derived cannabinoid market is competitive with many seed and genetics providers. Competitors include companies specializing in agricultural seeds and biotechnology.
- Hemp Biomass/Extracts (Potential Future Offerings): While the primary focus is on plant genetics, the company may also engage in the cultivation and sale of hemp biomass or cannabinoid extracts. The market for CBD and other hemp-derived cannabinoids is significant but highly fragmented and competitive. Major players in the broader cannabinoid market include large CPG companies with CBD product lines and specialized extractors.
Market Dynamics
Industry Overview
22nd Century Group operates in the rapidly evolving plant biotechnology and cannabinoid industries. The hemp industry has seen significant growth following the 2018 Farm Bill, which legalized hemp production. The market is characterized by innovation in plant genetics, extraction technologies, and consumer product development. Regulatory landscapes, particularly concerning cannabis, continue to be a major factor.
Positioning
22nd Century Group positions itself as a leader in proprietary plant genetics for the hemp and potentially cannabis industries. Its competitive advantage lies in its long-standing expertise in plant breeding and its focus on developing high-yield, trait-specific plant lines. The company aims to be a key supplier of genetics to growers and extractors.
Total Addressable Market (TAM)
The TAM for hemp-derived cannabinoids and related products is substantial and growing, with estimates varying widely but often in the billions of dollars globally. 22nd Century Group is positioned to capture a portion of this market by providing the foundational plant genetics necessary for its cultivation and production.
Upturn SWOT Analysis
Strengths
- Proprietary plant genetics and breeding technology.
- Experienced leadership in plant science.
- Focus on high-yield, trait-specific hemp plants.
- Potential for expansion into broader plant biotechnology applications.
Weaknesses
- Dependence on the evolving regulatory landscape for hemp and cannabis.
- Relatively small market share in a competitive agricultural input market.
- History of financial losses and reliance on external funding.
- Execution risk associated with scaling operations and product commercialization.
Opportunities
- Growth in the global hemp and cannabinoid market.
- Expansion into new geographic markets.
- Development of new plant varieties for various applications (e.g., industrial hemp, specialty cannabinoids).
- Strategic partnerships and acquisitions.
Threats
- Increasing competition from other genetics providers and large agricultural companies.
- Unfavorable regulatory changes or enforcement.
- Commoditization of hemp and cannabinoid prices.
- Challenges in supply chain and distribution.
- Economic downturns impacting consumer spending on related products.
Competitors and Market Share
Key Competitors
- Any other US company involved in hemp genetics or cannabinoid cultivation.
Competitive Landscape
22nd Century Group's advantage lies in its proprietary genetics. However, it faces competition from established agricultural seed companies and numerous smaller players in the burgeoning hemp sector. Its scale and financial resources may be a disadvantage compared to larger agricultural corporations.
Growth Trajectory and Initiatives
Historical Growth: The company has experienced revenue growth in some periods, driven by its entry and expansion in the hemp market. However, consistent profitability and sustainable growth have been a challenge.
Future Projections: Future growth projections are contingent on the successful commercialization of its plant genetics, expansion into new markets, and favorable regulatory developments. Analyst estimates are often varied and subject to significant revisions.
Recent Initiatives: Recent initiatives have included a focus on hemp and cannabinoid product development, strategic partnerships, and efforts to improve operational efficiency.
Summary
22nd Century Group Inc. is a plant biotechnology company focused on hemp and cannabinoid genetics. While it possesses strong proprietary technology and operates in a growing market, it faces significant challenges with consistent profitability, competition, and regulatory uncertainty. Its success hinges on its ability to scale operations, secure new markets, and navigate a complex legal landscape.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Financial news outlets
- Industry research reports
- Company investor relations materials
Disclaimers:
This JSON output is for informational purposes only and does not constitute financial advice. Market share data and financial figures are estimates and subject to change. Investors should conduct their own due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About 22nd Century Group Inc
Exchange NASDAQ | Headquaters Mocksville, NC, United States | ||
IPO Launch date 2011-01-26 | President, CEO & Director Mr. Lawrence D. Firestone | ||
Sector Consumer Defensive | Industry Tobacco | Full time employees 56 | Website https://www.xxiicentury.com |
Full time employees 56 | Website https://www.xxiicentury.com | ||
22nd Century Group, Inc., a tobacco products company, manufactures, distributes, and sells proprietary new reduced nicotine tobacco products in the United States. The company offers reduced nicotine content tobacco and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands, as well as turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Mocksville, North Carolina.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.